Literature DB >> 10620642

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group.

P C van den Hoogen1, E J Feskens, N J Nagelkerke, A Menotti, A Nissinen, D Kromhout.   

Abstract

BACKGROUND: Elevated blood pressure is known to be a risk factor for death from coronary heart disease (CHD). However, it is unclear whether the risk of death from CHD in relation to blood pressure varies among populations.
METHODS: In six populations in different parts of the world, we examined systolic and diastolic blood pressures and hypertension in relation to long-term mortality from CHD, both with and without adjustment for variability in blood pressure within individual subjects. Blood pressure was measured at base-line in 12,031 men (age range, 40 to 59 years) who were free of CHD. During 25 years of follow-up, 1291 men died from CHD.
RESULTS: At systolic and diastolic blood pressures of about 140 and 85 mm Hg, respectively, 25-year rates of mortality from CHD (standardized for age) varied by a factor of more than three among the populations. Rates in the United States and northern Europe were high (approximately 70 deaths per 10,000 person-years), but rates in Japan and Mediterranean southern Europe were low (approximately 20 deaths per 10,000 person-years). However, the relative increase in 25-year mortality from CHD for a given increase in blood pressure was similar among the populations. The overall unadjusted relative risk of death due to CHD was 1.17 (95 percent confidence interval, 1.14 to 1.20) per 10 mm Hg increase in systolic pressure and 1.13 (95 percent confidence interval, 1.10 to 1.15) per 5 mm Hg increase in diastolic pressure, and it was 1.28 for each of these increments after adjustment for within-subject variability in blood pressure.
CONCLUSIONS: Among the six populations we studied, the relative increase in long-term mortality due to CHD for a given increase in blood pressure is similar, whereas the absolute risk at the same level of blood pressure varies substantially. If the absolute risk of CHD is used as an indication for antihypertensive therapy, these findings will have major implications for treatment in different parts of the world.

Entities:  

Mesh:

Year:  2000        PMID: 10620642     DOI: 10.1056/NEJM200001063420101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  93 in total

1.  Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study.

Authors:  A Menotti; H Blackburn; D Kromhout; A Nissinen; H Adachi; M Lanti
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Antihypertensive drug therapy in the third millennium: are there benefits beyond blood pressure?

Authors:  S E Bakir; S Oparil
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 3.  Diastolic pressure, systolic pressure, or pulse pressure?

Authors:  C Vlachopoulos; M O'Rourke
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 4.  Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review.

Authors:  R Padwal; S E Straus; F A McAlister
Journal:  BMJ       Date:  2001-04-21

5.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors:  A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

6.  Testing for population subdivision and association in four case-control studies.

Authors:  Kristin G Ardlie; Kathryn L Lunetta; Mark Seielstad
Journal:  Am J Hum Genet       Date:  2002-07-02       Impact factor: 11.025

7.  Twenty-five-year coronary mortality trends in the seven countries study using the accelerated failure time model.

Authors:  A Menotti; P E Puddu; M Lanti; D Kromhout; H Blackburn; A Nissinen
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 8.  Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease.

Authors:  Monisankar Roy; Noman Mahmood; Clive Rosendorff
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

9.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

10.  Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.

Authors:  J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.